Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Apr 1;332(7544):756-61.
doi: 10.1136/bmj.38782.575868.7C. Epub 2006 Mar 16.

Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial

Jane Fossey  1 , Clive Ballard, Edmund Juszczak, Ian James, Nicola Alder, Robin Jacoby, Robert Howard
Affiliations
Randomized Controlled Trial

Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial

Jane Fossey et al. BMJ. .

Erratum in

  • BMJ. 2006 Apr 1;332(7544):61

Abstract

Objective: To evaluate the effectiveness of a training and support intervention for nursing home staff in reducing the proportion of residents with dementia who are prescribed neuroleptics.

Design: Cluster randomised controlled trial with blinded assessment of outcome.

Setting: 12 specialist nursing homes for people with dementia in London, Newcastle, and Oxford.

Participants: Residents of the 12 nursing homes; numbers varied during the study period.

Intervention: Training and support intervention delivered to nursing home staff over 10 months, focusing on alternatives to drugs for the management of agitated behaviour in dementia.

Main outcome measures: Proportion of residents in each home who were prescribed neuroleptics and mean levels of agitated and disruptive behaviour (Cohen-Mansfield agitation inventory) in each home at 12 months.

Results: At 12 months the proportion of residents taking neuroleptics in the intervention homes (23.0%) was significantly lower than that in the control homes (42.1%): average reduction in neuroleptic use 19.1% (95% confidence interval 0.5% to 37.7%). No significant differences were found in the levels of agitated or disruptive behaviour between intervention and control homes.

Conclusions: Promotion of person centred care and good practice in the management of patients with dementia with behavioural symptoms provides an effective alternative to neuroleptics.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flow of nursing homes and residents through trial
Fig 2
Fig 2
Neuroleptic use at baseline and 12 months in homes allocated to training and support intervention or to treatment as usual (size of circle proportional to size of cluster). As control homes have almost identical proportions of residents taking neuroleptics at 12 months, points overlap and appear to be only five
Fig 3
Fig 3
Percentage of residents prescribed neuroleptics in each home (size of circle proportional to size of home). Diagonal line represents no change in percentage of residents taking neuroleptics from baseline to 12 months. Homes above line experienced increase in percentage of residents taking neuroleptics and homes below line experienced decrease. Homes near line show little change
Fig 4
Fig 4
Neuroleptic use over study period, July 2003 to June 2004
See this image and copyright information in PMC

Comment in

References

    1. McGrath AM, Jackson GA. Survey of prescribing in residents of nursing homes in Glasgow. BMJ 1996;314: 611-2. - PMC - PubMed
    1. Margallo-Lana M, Swann A, O'Brien J, Fairbairn A, Reichelt K, Potkins D, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatr 2001;16: 39-44. - PubMed
    1. DeDeyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, et al. A randomised trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia. Neurol 1999;53: 946-55. - PubMed
    1. Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, et al. Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: a double-blind randomised, placebo-controlled trial. Arch Gen Psychiatr 2000;57: 968-76. - PubMed
    1. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293: 596-608. - PubMed

Publication types

Substances